檢索結果 - Persson, Frederik

Empagliflozin reduces albuminuria—a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial 由 Borg, Rikke, Persson, Frederik

獲取全文 獲取全文 獲取全文

Diagnosis of diabetic kidney disease: state of the art and future perspective 由 Persson, Frederik, Rossing, Peter

獲取全文 獲取全文 獲取全文

A narrative review of new treatment options for chronic kidney disease in type 2 diabetes 由 Persson, Frederik, Borg, Rikke, Rossing, Peter

獲取全文 獲取全文 獲取全文

Direct renin inhibition in chronic kidney disease 由 Persson, Frederik, Rossing, Peter, Parving, Hans-Henrik

獲取全文 獲取全文 獲取全文

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease 由 Persson, Frederik, Frimodt-Møller, Marie, Rossing, Peter

獲取全文 獲取全文 獲取全文

Mitigating risk of aldosterone in diabetic kidney disease 由 Frimodt-Møller, Marie, Persson, Frederik, Rossing, Peter

獲取全文 獲取全文 獲取全文

Tissue Renin–Angiotensin Systems: A Unifying Hypothesis of Metabolic Disease 由 Skov, Jeppe, Persson, Frederik, Frøkiær, Jørgen, Christiansen, Jens Sandahl

獲取全文 獲取全文 獲取全文

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review 由 Persson, Frederik, Lindhardt, Morten, Rossing, Peter, Parving, Hans-Henrik

獲取全文 獲取全文 獲取全文

Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes 由 Theilade, Simone, Lajer, Maria, Persson, Frederik, Joergensen, Christel, Rossing, Peter

獲取全文 獲取全文 獲取全文

Linking Kidney and Cardiovascular Complications in Diabetes—Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture 由 Rossing, Peter, Persson, Frederik, Frimodt-Møller, Marie, Hansen, Tine Willum

獲取全文 獲取全文 獲取全文

Discrepancy Between Tonometric Ambulatory and Cuff‐Based Office Blood Pressure Measurements in Patients With Type 1 Diabetes 由 Theilade, Simone, Lajer, Maria, Joergensen, Christel, Persson, Frederik, Rossing, Peter

獲取全文 獲取全文 獲取全文

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria 由 Rathcke, Camilla Noelle, Persson, Frederik, Tarnow, Lise, Rossing, Peter, Vestergaard, Henrik

獲取全文 獲取全文 獲取全文

Is Time-Restricted Eating Safe in the Treatment of Type 2 Diabetes?—A Review of Intervention Studies 由 Uldal, Sarah, Clemmensen, Kim Katrine Bjerring, Persson, Frederik, Færch, Kristine, Quist, Jonas Salling

獲取全文 獲取全文 獲取全文

Effect of large weight reductions on measured and estimated kidney function 由 von Scholten, Bernt Johan, Persson, Frederik, Svane, Maria S., Hansen, Tine W., Madsbad, Sten, Rossing, Peter

獲取全文 獲取全文 獲取全文

Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy 由 Persson, Frederik, Lewis, Julia B., Lewis, Edmund J., Rossing, Peter, Hollenberg, Norman K., Parving, Hans-Henrik

獲取全文 獲取全文 獲取全文

Aliskiren in Combination with Losartan Reduces Albuminuria Independent of Baseline Blood Pressure in Patients with Type 2 Diabetes and Nephropathy 由 Persson, Frederik, Lewis, Julia B., Lewis, Edmund J., Rossing, Peter, Hollenberg, Norman K., Parving, Hans-Henrik

獲取全文 獲取全文 獲取全文

Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function 由 Petrykiv, Sergei, Sjöström, C. David, Greasley, Peter J., Xu, John, Persson, Frederik, Heerspink, Hiddo J.L.

獲取全文 獲取全文 獲取全文

Urinary albumin and 8-oxo-7,8-dihydroguanosine as markers of mortality and cardiovascular disease during 19 years after diagnosis of type 2 diabetes – A comparative study of two ma... 由 Broedbaek, Kasper, Køster-Rasmussen, Rasmus, Siersma, Volkert, Persson, Frederik, Poulsen, Henrik E., de Fine Olivarius, Niels

獲取全文 獲取全文 獲取全文

Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: Individual effects of treatment 由 Zobel, Emilie H., von Scholten, Bernt J., Goldman, Bryan, Persson, Frederik, Hansen, Tine W., Rossing, Peter

獲取全文 獲取全文 獲取全文

Importance of standardizing renal outcomes in clinical trials: illustration by recent SGLT2 inhibitor studies 由 van Raalte, Daniël H., Bjornstad, Petter, Heerspink, Hiddo J.L., Persson, Frederik, Cherney, David Z.I.

獲取全文 獲取全文 獲取全文